Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The British Heart Foundation (BHF) has awarded the University of Oxford £6 million to further develop the Oxford BHF Centre of Research Excellence (Oxford BHF CRE) for the next 5 years.

© Shutterstock

With this new round of funding, the Oxford BHF CRE has four key research themes, in areas where it sees clear potential to deliver world leading advances. The CRE will marshal multidisciplinary resources to make a concerted effort in important, tractable areas of cardiovascular science and medicine where Oxford scientists believe they can make a difference. In doing this the CRE expects to further raise the level of ambition and the scope for delivery for people living with heart disease.  

Read more (BHF CRE / Oxford Cardivascular Science website)

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.